On the Role of Interleukin-2 (IL-2) in Multiple Sclerosis (MS). IL-2-mediated Endothelial Cell Activation
Overview
Affiliations
Increased serum levels of IL-2 and sIL-2R can be demonstrated in patients with active MS, a finding that strongly supports the hypothesis of a systemic T cell activation in such patients. However, IL-2 may play a crucial role in MS immunopathology by activating endothelial cells, as suggested by the vascular leak syndrome complicating hrIL-2 therapy. Early BBB impairment and focal perivascular edema that characterize MS lesions may be the effect of an IL-2-induced cytokine cascade.
Faraji J, Bettenson D, Babatunde S, Gangur-Powell T, Yong V, Metz G Brain Behav Immun Health. 2022; 23:100477.
PMID: 35677535 PMC: 9167694. DOI: 10.1016/j.bbih.2022.100477.
Yan J, McCombe P, Pender M, Greer J J Clin Med. 2020; 9(8).
PMID: 32781504 PMC: 7465818. DOI: 10.3390/jcm9082534.
Wylezinski L, Hawiger J J Biol Chem. 2016; 291(44):22913-22923.
PMID: 27601468 PMC: 5087713. DOI: 10.1074/jbc.M116.729038.
Morris G, Maes M BMC Med. 2013; 11:205.
PMID: 24229326 PMC: 3847236. DOI: 10.1186/1741-7015-11-205.
Orandle M, Williams K, MacLean A, Westmoreland S, Lackner A J Virol. 2001; 75(9):4448-52.
PMID: 11287599 PMC: 114195. DOI: 10.1128/JVI.75.9.4448-4452.2001.